These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 21392058)

  • 1. Inhibitors of the initiation of coagulation.
    Ott I
    Br J Clin Pharmacol; 2011 Oct; 72(4):547-52. PubMed ID: 21392058
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tissue factor pathway.
    McVey JH
    Baillieres Best Pract Res Clin Haematol; 1999 Sep; 12(3):361-72. PubMed ID: 10856975
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibitors of Tissue Factor. Factor VIIa for anticoagulant therapy.
    Lazarus RA; Olivero AG; Eigenbrot C; Kirchhofer D
    Curr Med Chem; 2004 Sep; 11(17):2275-90. PubMed ID: 15379712
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Inactivated factor VII exercises a powerful antithrombotic activity in an experimental model of recurrent arterial thrombosis].
    Ragni M; Golino P; Cirillo P; Pascucci I; Scognamiglio A; Ravera A; Esposito N; Battaglia C; Guarino A; Chiariello M
    Cardiologia; 1996 Jan; 41(1):51-8. PubMed ID: 8697470
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hemextin AB complex, a unique anticoagulant protein complex from Hemachatus haemachatus (African Ringhals cobra) venom that inhibits clot initiation and factor VIIa activity.
    Banerjee Y; Mizuguchi J; Iwanaga S; Kini RM
    J Biol Chem; 2005 Dec; 280(52):42601-11. PubMed ID: 16204244
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibitors of Factor VIIa/tissue factor.
    Shirk RA; Vlasuk GP
    Arterioscler Thromb Vasc Biol; 2007 Sep; 27(9):1895-900. PubMed ID: 17600222
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tissue factor - a therapeutic target for thrombotic disorders.
    Houston DS
    Expert Opin Ther Targets; 2002 Apr; 6(2):159-74. PubMed ID: 12223078
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel exosite on coagulation factor VIIa and its molecular interactions with a new class of peptide inhibitors.
    Roberge M; Santell L; Dennis MS; Eigenbrot C; Dwyer MA; Lazarus RA
    Biochemistry; 2001 Aug; 40(32):9522-31. PubMed ID: 11583151
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recombinant nematode anticoagulant protein c2 and other inhibitors targeting blood coagulation factor VIIa/tissue factor.
    Lee AY; Vlasuk GP
    J Intern Med; 2003 Oct; 254(4):313-21. PubMed ID: 12974870
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of an anticoagulant peptide that inhibits both fXIa and fVIIa/tissue factor from the blood-feeding nematode Ancylostoma caninum.
    Li D; He Q; Kang T; Yin H; Jin X; Li H; Gan W; Yang C; Hu J; Wu Y; Peng L
    Biochem Biophys Res Commun; 2010 Feb; 392(2):155-9. PubMed ID: 20059979
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulators of the coagulation cascade: focus and recent advances in inhibitors of tissue factor, factor VIIa and their complex.
    Frédérick R; Pochet L; Charlier C; Masereel B
    Curr Med Chem; 2005; 12(4):397-417. PubMed ID: 15720249
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The factor VII zymogen structure reveals reregistration of beta strands during activation.
    Eigenbrot C; Kirchhofer D; Dennis MS; Santell L; Lazarus RA; Stamos J; Ultsch MH
    Structure; 2001 Jul; 9(7):627-36. PubMed ID: 11470437
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tissue factor coagulation pathway and blood cells activation state in renal insufficiency.
    Mercier E; Branger B; Vecina F; Al-Sabadani B; Berlan J; Dauzat M; Fourcade J; Gris JC
    Hematol J; 2001; 2(1):18-25. PubMed ID: 11920229
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A cyclic pentapeptide derived from the second EGF-like domain of Factor VII is an inhibitor of tissue factor dependent coagulation and thrombus formation.
    Orning L; Fischer PM; Hu CK; Agner E; Engebretsen M; Husbyn M; Petersen LB; Orvim U; Llinas M; Sakariassen KS
    Thromb Haemost; 2002 Jan; 87(1):13-21. PubMed ID: 11848442
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of activated factor VII in a cell-based model for tissue factor-initiated coagulation.
    Kjalke M; Monroe DM; Hoffman M; Oliver JA; Ezban M; Hedner U; Roberts HR
    Blood Coagul Fibrinolysis; 1998 Mar; 9 Suppl 1():S21-5. PubMed ID: 9819025
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coagulation factors VII and X induce Ca2+ oscillations in Madin-Darby canine kidney cells only when proteolytically active.
    Camerer E; Rottingen JA; Iversen JG; Prydz H
    J Biol Chem; 1996 Nov; 271(46):29034-42. PubMed ID: 8910556
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tissue factor upregulation drives a thrombosis-inflammation circuit in relation to cardiovascular complications.
    Chu AJ
    Cell Biochem Funct; 2006; 24(2):173-92. PubMed ID: 15617024
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New insights into how blood clots: implications for the use of APTT and PT as coagulation screening tests and in monitoring of anticoagulant therapy.
    Bajaj SP; Joist JH
    Semin Thromb Hemost; 1999; 25(4):407-18. PubMed ID: 10548073
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Generation of potent coagulation protease inhibitors utilizing zinc-mediated chelation.
    Young WB; Sprengeler P; Shrader WD; Li Y; Rai R; Verner E; Jenkins T; Fatheree P; Kolesnikov A; Janc JW; Cregar L; Elrod K; Katz B
    Bioorg Med Chem Lett; 2006 Feb; 16(3):710-3. PubMed ID: 16257204
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The action of high-dose factor VIIa (FVIIa) in a cell-based model of hemostasis.
    Hoffman M; Monroe DM
    Dis Mon; 2003 Jan; 49(1):14-21. PubMed ID: 12525825
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.